July 20, 2022
Shionogi said on July 19 that it has kicked off a Japanese clinical trial for its COVID-19 vaccine S-268019 in children aged five through 11. The Osaka-based drug maker launched Part 1 of the PI/II/III trial, which is designed to...read more